Investor Information

Decision Diagnostics is a small and friendly oriented company with headquarters centered in the picturesque Westlake Village, California. Decision Diagnostics specializes in prescription, non-prescription diagnostics, and home testing products. Through our subsidiary, PharmaTech Solutions, Inc., we provide blood glucose home testing test strips and exciting new concepts for blood testing monitors! All of our products are FDA cleared and have entered the market as an economical alternative for patients and healthcare providers. The quality, accuracy, and affordability of our products are unmatched and easily accessible. Learn More

Investor Resources

Latest Financial Report

Filing Date	Type	View	Download
Nov 16	Quarterly Report for period ended 09/30/2020
	Management Discussion and Analysis
	Supplemental Information

(View all financial reports)

Latest Press Releases

• DECN to Announce Various Testing Results This Week for Its COVID-19 GenViro! Swift Kit (December 21)
• DECN Comments on Recent Legal Filings by Federal Agencies (December 18)
• DECN Provides Testing Update for US, Korea and XPRIZE With Plans for Walk-in Donor Study for at-Home GenViro! Saliva Swift :10 Test Kit (December 16)
• DECN Secures Exclusive Distributor Agreement With a German Based Company for the Distribution of Genviro! Covid-19 :10 Saliva Testing Kits and Meters in 18 EU Countries, Norway and the UK (December 10)
• DECN Announces Significant Agreement With Russian Federation Partner for Genviro! and Genviro! Pro COVID-19 Testing Kits as Well as Its Venerable GenUltimate! Blood Glucose Products (December 1)

(View all press releases)